Found: 26
Select item for more details and to access through your institution.
Can Precision Oncology Benefit Patients With Cancers of Unknown Primary?
- Published in:
- 2023
- By:
- Publication type:
- Editorial
The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 832, doi. 10.1093/oncolo/oyad233
- By:
- Publication type:
- Article
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 845, doi. 10.1093/oncolo/oyad139
- By:
- Publication type:
- Article
Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2− Advanced Breast Cancer: Findings From a Multicountry Survey.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 856, doi. 10.1093/oncolo/oyad207
- By:
- Publication type:
- Article
Real-World Effectiveness of Palbociclib Plus Aromatase Inhibitors in African American Patients With Metastatic Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 866, doi. 10.1093/oncolo/oyad209
- By:
- Publication type:
- Article
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 875, doi. 10.1093/oncolo/oyad257
- By:
- Publication type:
- Article
Impact of Anti-EGFR Therapies on HER2-Positive Metastatic Colorectal Cancer: A Systematic Literature Review and Meta-Analysis of Clinical Outcomes.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 885, doi. 10.1093/oncolo/oyad200
- By:
- Publication type:
- Article
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 894, doi. 10.1093/oncolo/oyad132
- By:
- Publication type:
- Article
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 901, doi. 10.1093/oncolo/oyad114
- By:
- Publication type:
- Article
Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 911, doi. 10.1093/oncolo/oyad219
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 917, doi. 10.1093/oncolo/oyad144
- By:
- Publication type:
- Article
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. 919, doi. 10.1093/oncolo/oyad164
- By:
- Publication type:
- Article
Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e847, doi. 10.1093/oncolo/oyad217
- By:
- Publication type:
- Article
Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e859, doi. 10.1093/oncolo/oyad127
- By:
- Publication type:
- Article
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e867, doi. 10.1093/oncolo/oyad137
- By:
- Publication type:
- Article
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e877, doi. 10.1093/oncolo/oyad152
- By:
- Publication type:
- Article
Healthcare Professional Communication on Sexual Health: A Report from the Italian Working Group on Adolescents and Young Adults with Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e884, doi. 10.1093/oncolo/oyad175
- By:
- Publication type:
- Article
Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World Study.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e891, doi. 10.1093/oncolo/oyad108
- By:
- Publication type:
- Article
The Frequency of Specific KRAS Mutations, and Their Impact on Treatment Choice and Survival, in Patients With Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e902, doi. 10.1093/oncolo/oyad117
- By:
- Publication type:
- Article
Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e910, doi. 10.1093/oncolo/oyad120
- By:
- Publication type:
- Article
The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e921, doi. 10.1093/oncolo/oyad056
- By:
- Publication type:
- Article
Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e930, doi. 10.1093/oncolo/oyad121
- By:
- Publication type:
- Article
Development of a Multivariate Prognostic Model for Lenvatinib Treatment in Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e942, doi. 10.1093/oncolo/oyad107
- By:
- Publication type:
- Article
Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e950, doi. 10.1093/oncolo/oyad135
- By:
- Publication type:
- Article
Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e973, doi. 10.1093/oncolo/oyad249
- By:
- Publication type:
- Article
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e977, doi. 10.1093/oncolo/oyad213
- By:
- Publication type:
- Article